Sanara MedTech Management
Management criteria checks 2/4
Sanara MedTech's CEO is Ron Nixon, appointed in May 2024, has a tenure of 6.17 years. total yearly compensation is $855.76K, comprised of 13.6% salary and 86.4% bonuses, including company stock and options. directly owns 11.57% of the company’s shares, worth $31.24M. The average tenure of the management team and the board of directors is 1.1 years and 3.9 years respectively.
Key information
Ron Nixon
Chief executive officer
US$855.8k
Total compensation
| CEO salary percentage | 13.63% |
| CEO tenure | 1yr |
| CEO ownership | 11.6% |
| Management average tenure | 1.1yrs |
| Board average tenure | 3.9yrs |
Recent management updates
Recent updates
Tissue Health Plus And OsStic Will Expand Market Reach
Expansion in sales coverage and partnerships aims to boost product adoption, enhancing revenue in both new and existing markets.Sanara MedTech: A Promising Growth Story At An Attractive Valuation
Jan 30Sanara MedTech (NASDAQ:SMTI) Is Carrying A Fair Bit Of Debt
Dec 19
US$44.00: That's What Analysts Think Sanara MedTech Inc. (NASDAQ:SMTI) Is Worth After Its Latest Results
Nov 15Sanara MedTech Inc. (NASDAQ:SMTI) Looks Just Right With A 28% Price Jump
Sep 05Here's Why Sanara MedTech (NASDAQ:SMTI) Can Afford Some Debt
Aug 14Sanara MedTech Inc.'s (NASDAQ:SMTI) Shares Not Telling The Full Story
May 23Is Sanara MedTech (NASDAQ:SMTI) Using Too Much Debt?
Nov 15Investors Still Waiting For A Pull Back In Sanara MedTech Inc. (NASDAQ:SMTI)
May 22Sanara MedTech Inc. (NASDAQ:SMTI) Analysts Are Pretty Bullish On The Stock After Recent Results
Mar 22Sanara MedTech: Differentiated Offering With Niche Wound Care Exposure
Sep 06Sanara MedTech reports Q2 results
Aug 15Here's Why We're Not At All Concerned With Sanara MedTech's (NASDAQ:SMTI) Cash Burn Situation
Dec 31Sanara MedTech: Technology For Faster Healing Wounds
Dec 08Companies Like Sanara MedTech (NASDAQ:SMTI) Can Afford To Invest In Growth
May 18The Sanara MedTech (NASDAQ:SMTI) Share Price Has Soared 510%, Delighting Many Shareholders
Feb 19
Is Sanara MedTech Inc. (NASDAQ:SMTI) Popular Amongst Insiders?
Dec 28CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2025 | n/a | n/a | -US$11m |
| Dec 31 2024 | US$856k | US$117k | -US$10m |
| Sep 30 2024 | n/a | n/a | -US$8m |
| Jun 30 2024 | n/a | n/a | -US$7m |
| Mar 31 2024 | n/a | n/a | -US$5m |
| Dec 31 2023 | US$408k | n/a | -US$4m |
| Sep 30 2023 | n/a | n/a | -US$8m |
| Jun 30 2023 | n/a | n/a | -US$9m |
| Mar 31 2023 | n/a | n/a | -US$6m |
| Dec 31 2022 | US$139k | n/a | -US$8m |
| Sep 30 2022 | n/a | n/a | -US$7m |
| Jun 30 2022 | n/a | n/a | -US$8m |
| Mar 31 2022 | n/a | n/a | -US$10m |
| Dec 31 2021 | US$352k | n/a | -US$8m |
| Sep 30 2021 | n/a | n/a | -US$5m |
| Jun 30 2021 | n/a | n/a | -US$4m |
| Mar 31 2021 | n/a | n/a | -US$4m |
| Dec 31 2020 | US$81k | n/a | -US$4m |
Compensation vs Market: Ron's total compensation ($USD855.76K) is below average for companies of similar size in the US market ($USD1.69M).
Compensation vs Earnings: Ron's compensation has increased whilst the company is unprofitable.
CEO
Ron Nixon (68 yo)
Mr. Ronald T. Nixon, also known as Ron, has been a Director at Sanara MedTech Inc. (formerly WNDM Medical Inc.) since March 15, 2019 and serves as its Executive Chairman since May 2019 & serves as its Chie...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman & CEO | 1yr | US$855.76k | 11.57% $ 31.2m | |
| Chief Operating Officer | 1.1yrs | US$566.68k | 0.13% $ 349.9k | |
| Chief Accounting & Administrative Officer and Corporate Secretary | less than a year | US$529.26k | 0.35% $ 939.4k | |
| Chief Financial Officer | less than a year | no data | no data | |
| Chief Compliance Officer | 5.3yrs | no data | no data | |
| Vice President of Marketing | no data | no data | no data | |
| Chief Corporate Development & Strategy Officer | 1.1yrs | no data | no data | |
| President of Telehealth Services | 4.6yrs | US$375.69k | no data | |
| President of Research & Development | 3.8yrs | no data | no data | |
| President of Commercial | 1.8yrs | no data | 0.69% $ 1.9m | |
| Vice President of Corporate Operations | no data | no data | no data | |
| Executive Officer | no data | no data | 0.033% $ 90.3k |
Experienced Management: SMTI's management team is not considered experienced ( 1.1 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman & CEO | 6.2yrs | US$855.76k | 11.57% $ 31.2m | |
| Independent Director | 3.3yrs | US$117.83k | 0.16% $ 427.5k | |
| Independent Director | 3.3yrs | US$112.70k | 0.15% $ 398.1k | |
| Independent Director | less than a year | US$69.13k | 0.022% $ 60.0k | |
| Independent Director | 4.6yrs | US$122.95k | 0.22% $ 591.2k | |
| Director | 5.8yrs | US$269.91k | 0.22% $ 604.6k | |
| Independent Director | 1.9yrs | US$107.57k | 0.069% $ 185.6k | |
| Independent Director | 4.4yrs | US$107.57k | 0.20% $ 532.5k |
Experienced Board: SMTI's board of directors are considered experienced (3.9 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/27 00:36 |
| End of Day Share Price | 2025/05/27 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Sanara MedTech Inc. is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ross Osborn | Cantor Fitzgerald & Co. |
| Yi Chen | H.C. Wainwright & Co. |